CDNA logo

CareDx Inc. (CDNA)$21.63

Market Cap: 843.40 MCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for CareDx Inc. (CDNA).

HEALTHCARE
DIAGNOSTICS & RESEARCH
DCF ready

Valuation

18.5x

EV/FCF, 5.4% FCF yield

Quality

-7.0%

ROIC, 11.1% FCF margin

Growth

14.6%

5Y sales (revenue) CAGR

Balance sheet

0.0x

Debt/equity, 2.9x current ratio

Superinvestors

1

Top: First Eagle Investment Management (0.0%)

Strengths to research

  • Revenue compounded at 14.6% over five years.
  • Debt/equity looks manageable at 0.0x.
  • 10 annual periods are available for trend analysis.

Watchouts

No major valuation, balance sheet, or growth watchouts were detected by the static screen.

Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for CDNA.

Grade D
40
/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
CDNA
Target
CareDx Inc.$843.4M-54.1x18.5x-7.0%14.6%11.1%N/AN/AN/A
RCKTRocket Pharmaceuticals Inc.$838.3M-1.5x-4.0x-80.5%N/AN/AN/AN/AN/A
INMDInMode Ltd.$868.1M9.6x6.7x13.7%12.4%22.7%78.5%-3.5xN/A
NUVBNuvation Bio Inc.$808.4M-7.9x-4.0x-58.0%N/A-275.7%N/AN/AN/A
AMNAMN Healthcare Services$759.4M-11.2x6.4x-6.8%2.7%8.6%28.3%7.2xN/A
EMBCEmbecta Corp$724.4M2.0x10.4x12.8%-0.1%16.9%62.6%4.1xN/A
AORTArtivion Inc.$1.0B107.0x1388.5x1.5%11.8%0.2%64.4%2.7xN/A
PHVSPharvaris NV$1.0BN/AN/AN/AN/AN/AN/AN/AN/A
IARTIntegra LifeSciences Holdings$1.0B-2.2x-48.9x-29.2%3.6%-1.9%N/AN/AN/A

Financial Charts

No financial data available for CDNA (annual).

1 superinvestors own CDNA

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
First Eagle Investment Management

First Eagle Investment Management

575,365$10M0.02%0.0%